Related Experiment Videos
Limiting treatment for extremely premature, low-birth-weight infants (500 to 750 g)
1Department of Health Policy Research, University School of Medicine, Stanford, CA 94305.
Insights
Outcomes for extremely premature infants remain challenging. An individualized approach to neonatal care balances ethical principles and resource allocation, prioritizing patient well-being over absolute certainty.
Area of Science:
- Neonatology
- Medical Ethics
- Public Health
Background:
- Despite advances, outcomes for extremely low-birth-weight infants (500-750g) are inconsistent.
- Ethical dilemmas arise between aggressive treatment, nonmaleficence, justice, and beneficence.
- The
- Baby Doe Regulations
- add complexity to decision-making.
Purpose of the Study:
- To explore the ethical quandaries in managing extremely premature infants.
- To present international perspectives on this neonatal care dilemma.
- To advocate for an individualized prognostic strategy.
Main Methods:
- Review of ethical principles (nonmaleficence, justice, beneficence).
- Analysis of the
- Baby Doe Regulations
- impact.
- Presentation of Stanford University's
- individualized prognostic strategy
- as a model.
Main Results:
- Vigorous treatment or withholding treatment both pose ethical challenges.
- An
- individualized prognostic strategy
- is favored over a
- wait until certainty
- approach.
- International perspectives highlight diverse approaches to this dilemma.
Conclusions:
- The
- individualized prognostic strategy
- at Stanford prioritizes patient-centered care.
- Urgent need to address prevention, stopping aggressive therapy, resource limitations, and redefining autonomy in neonatal care.
- Further discussion is needed on these complex ethical and practical issues.
Abstract:
Despite impressive recent advances in neonatology, outcomes for extremely premature, very-low-birth-weight infants (500 to 750 g) remain uneven. In a situation of inherent uncertainty, treating patients vigorously could do violence to the moral principles of nonmaleficence and (distributive) justice. Equally, failing to treat patients vigorously because of concerns about nonmaleficence and (distributive) justice could violate the principle of patient-centered beneficence. Compounding this dilemma is the legacy of the "Baby Doe Regulations." International perspectives on this particular quandary are provided. We assert that at Stanford (Calif) University the "individualized prognostic strategy" rather than the "wait until certainty" approach prevails. Four concluding questions are posed: Why is prevention not encouraged more than after-the-fact heroic intervention? Is it possible to develop a more rational view of stopping aggressive therapy once having started? Can we ignore the finitude of our medical resources? Is there a need to redefine the nature of autonomy?